# Propafenone

## Rhynorm 150mg

| TAH Drug Code      | [ORHY](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ORHY)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Ventricular & supraventricular tachyarrhythmias, Wolff-Parkinson-White syndrome.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Dosing             | Adult (70 kg): Initial and maintenance dose: 450-600 mg/day in 2-3 divided doses. May increase to 900 mg/day. Dosage may be adjusted in patients with lower body weight. Children: 10-20mg/kg/day in 3-4 divided doses.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | Manifest heart failure; cardiogenic shock (except for shock induced by arrhythmia); severe bradycardia within 3 months after MI; pre-existing high degree SA, AV & intraventricular disorders of impulse conduction; sick sinus syndrome; manifest disorders of electrolyte balance; severe obstructive pulmonary disease; marked hypotension, myasthenia gravis.                                                                                                                                                                                                                                                                                                                                                      |
| Adverse Effects    | May induce arrhythmia eg. bradycardia, induction disorder, tachycardia. Rarely ventricular fibrillation. May increase severity of heart failure. Hypotension. GI disturbances. Paresthesia, visual disturbances, dizziness. Rarely fatigue, headache, psychotic disorders. Blood disorders. Rarely, skin allergy, bronchospasm. Cardiovascular: Chest pain (1.8% ), Edema (5% to 13% ), Palpitations (3.4% ) Gastrointestinal: Constipation (8% to 14% ), Nausea (9% to 17% ), Taste sense altered (6% to 22% ), Vomiting (0% to 6% ) Neurologic: Dizziness (21% to 23% ) Psychiatric: Anxiety (10% to 13% ) Respiratory: Dyspnea (13% to 17% ), Upper respiratory infection (8% to 12% ) Other: Fatigue (11% to 13% ) |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Moderate Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| More Info          | [UpToDate](https://www.uptodate.com/contents/propafenone-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

